Baijin Life Science Holdings Limited

As of March 31, 2026, Affluent Partners Holdings Ltd. carries a market capitalization of 69.89M, placing it among publicly traded companies globally. Its enterprise value stands at 68.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Affluent Partners Holdings Ltd. has 932.25M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Affluent Partners Holdings Ltd. maintains a current ratio of 2.97, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on September 16, 2026, Affluent Partners Holdings Ltd. 's stock has gained approximately 87.50% over the past 52 weeks. The 50-day moving average sits at 0.05, while the 200-day moving average is 0.55.

As of March 31, 2026, Affluent Partners Holdings Ltd. holds 5.50M in cash and equivalents against 3.62M in total debt, resulting in a net debt position of -3.75M. Total book value stands at 23.63M, with working capital of 16.26M providing operational flexibility.

Affluent Partners Holdings Ltd. 's most recent stock split took place on April 6, 2022 with a 58:61 split ratio.